Ginkgo Bioworks Holdings, Inc. - Class A Common Stock (DNA)

CUSIP: 37611X209

Q1 2025 13F Holders as of 31 Mar 2025

Type / Class
Equity / Class A Common Stock
Shares outstanding
48,809,163
Total 13F shares
32,270,574
Share change
-426,078
Total reported value
$183,952,552
Put/Call ratio
138%
Price per share
$5.70
Number of holders
161
Value change
-$9,250,058
Number of buys
75
Number of sells
58

Quarterly Holders Quick Answers

What is CUSIP 37611X209?
CUSIP 37611X209 identifies DNA - Ginkgo Bioworks Holdings, Inc. - Class A Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Ginkgo Bioworks Holdings, Inc. - Class A Common Stock (DNA) as of Q1 2025

As of 31 Mar 2025, Ginkgo Bioworks Holdings, Inc. - Class A Common Stock (DNA) was held by 161 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 32,270,574 shares. The largest 10 holders included VIKING GLOBAL INVESTORS LP, BAILLIE GIFFORD & CO, VANGUARD GROUP INC, Anchorage Capital Group, L.L.C., Erste Asset Management GmbH, EcoR1 Capital, LLC, MILLENNIUM MANAGEMENT LLC, Legal & General Group Plc, BlackRock, Inc., and Opaleye Management Inc.. This page lists 161 institutional shareholders reporting positions in this security for the Q1 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.